Sixteen patients with TB-HIV co-infection received rifabutin @mg QD in combination with tuberculosis chemotherapy ( initially pyrazinamide , isoniazid and ethambutol then only isoniazid ) , and were then randomized to receive isoniazid and LPV/r based ART with rifabutin @mg tiw or rifabutin @mg daily .